CTLA4 and neoplasm: PD-L1 can be expressed on both tumour and tumour infiltrating immune cells and is often associated with an immunosuppressive microenvironment, characterized by the accumulation of regulatory T cells (Tregs), exhausted CD8+ T cells, and increased expression of additional inhibitory molecules such as CTLA-4 and TIM-3 [54].